60 Degrees Pharmaceuticals, Inc. (SXTP) Dividend History

Company News

• 60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format

  60 Degrees Pharmaceuticals has introduced a new 8-count bottle format for its malaria prevention drug ARAKODA, expanding options for healthcare professionals and travelers.

  GlobeNewswire Inc.
• Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®

  Sixty Degrees Pharmaceuticals announced that it will import a limited quantity of KODATEF® (tafenoquine) from Australia to ensure the continuity of ARAKODA® (tafenoquine) supply in the U.S. ARAKODA and KODATEF are identical products, and the company is taking this proactive step to maintain the availability of tafenoquine for malaria prophylaxis.

  GlobeNewswire Inc.
• US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings

  U.S. stock futures were mixed ahead of the Federal Reserve's interest rate decision and key earnings reports from major tech companies. Investors are cautious as they await the Fed's policy announcement and guidance.

  Benzinga

  Featured Companies: BNZI META MSFT QQQ SBUX SLXN SPY SYK TSLA
• 60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch

  60 Degrees Pharmaceuticals announced a promotional pilot for its antimalarial drug ARAKODA, which aims to increase brand awareness and utilization through virtual sales outreach and a co-pay program.

  GlobeNewswire Inc.
• 60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements

  60 Degrees Pharmaceuticals, Inc. has regained compliance with the Nasdaq's minimum bid price requirement, maintaining a closing price of $1.81 per share for at least 10 consecutive trading days.

  GlobeNewswire Inc.